BioSpace News Archive

Pharm Country

Wharton Research Data Services Adds Preqin Data, Covering Alternative Asset Markets

Wharton Research Data Services, the leading business intelligence, data analytics, and research platform for corporate, academic and government institutions worldwide, is pleased to announce the addition of Preqin private equity data to its offerings.

September 26, 2019
·
6 min read
Business

Alzheimer Society of Canada awards $2.1 million to Canadian dementia researchers and launches new competition

The Alzheimer Society of Canada is pleased to announce that it has invested $2.1 million in Canadian dementia research through the 2019 Alzheimer Society Research Program competition.

September 26, 2019
·
3 min read
Policy

Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

Issuance of New Patent and Allowance of Patent Application Diversifies SYN-010 Protection in US

September 26, 2019
·
6 min read
Pharm Country

Cipla Announces the Launch of Daptomycin for Injection, 500 mg/vial, Single-dose Vials (for Intravenous use only)

Cipla Limited and its subsidiary Cipla USA, Inc., announce the launch of Daptomycin for Injection, 500mg/vial, single-dose vial, AP-rated generic equivalent of Cubicin® for Injection in the United States.

September 26, 2019
·
2 min read
Genetown

Proteostasis Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

Proteostasis Therapeutics, Inc. announced that Proteostasis management will present at the 2019 Cantor Global Healthcare Conference on Thursday, October 3, 2019 at 8:55 a.m. ET at the InterContinental New York Barclay.

September 26, 2019
·
3 min read
Deals

Tetraphase Pharmaceuticals Announces Reverse Stock Split

Tetraphase Pharmaceuticals, Inc. announced that it will effect a 1-for-20 reverse stock split of its common stock that will be effective at 5:00 p.m. Eastern Time.

September 26, 2019
·
4 min read
Biotech Bay

Aimmune to Present at the Cantor Global Healthcare Conference

Aimmune Therapeutics, Inc. announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at the Cantor Global Healthcare Conference on Thursday, October 3, 2019 at 8:20 a.m. E.T. in New York City.

September 26, 2019
·
1 min read
FDA

FDA Approves Abbott’s “Low Dose,” Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain

Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company’s Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain.

September 26, 2019
·
7 min read
Deals

Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26

Emmaus Life Sciences, Inc. announced it is approved to have its common stock trade on the OTCQB marketplace, effective September 26, 2019.

September 26, 2019
·
3 min read
Drug Development

Galmed Pharmaceuticals Initiated ARMOR, a Phase 3/4 Registrational Study of Aramchol in Subjects With NASH and Fibrosis

Galmed Pharmaceuticals Ltd. announced the initiation of its Phase 3/4 ARMOR clinical study to evaluate the efficacy and safety of Aramchol in subjects with NASH and fibrosis.

September 26, 2019
·
7 min read